$ONCT Oncternal Therapeutics, Inc. Insider Trading
Get free email notifications about insider trading in Oncternal Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Oncternal Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Oncternal Therapeutics, Inc. for free.
CIK Number: 0001260990
IRS Number: 621715807
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: ONCT
Company Address: 12230 EL CAMINO REAL SUITE 300 SAN DIEGO 92130
Phone number: (858) 434-1113
Former name: GTX INC /DE/, date of change: 2003-08-22
Market Capitalization: $86.92M
Prev close: $5.58
Average Daily Volume: 79,148
Days Low: $5.45
Year Low: $5.00
Year High: $11.19
Oncternal Therapeutics, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 27 2021 | ONCT | Oncternal Therapeu ... | Wills Robert James | Director | Option Exercise | A | 5.14 | 25,000 | 128,500 | 25,000 | |
May 27 2021 | ONCT | Oncternal Therapeu ... | MAZANET ROSEMARY | Director | Option Exercise | A | 5.14 | 25,000 | 128,500 | 25,000 | |
Mar 22 2021 | ONCT | Oncternal Therapeu ... | BREITMEYER JAMES B | Chief Executive Off ... | Option Exercise | A | 0.81 | 63,295 | 51,269 | 105,492 | |
Feb 23 2021 | ONCT | Oncternal Therapeu ... | BREITMEYER JAMES B | Chief Executive Off ... | Option Exercise | A | 7.48 | 2,000 | 14,960 | 2,000 | |
Feb 23 2021 | ONCT | Oncternal Therapeu ... | BREITMEYER JAMES B | Chief Executive Off ... | Option Exercise | A | 5.33 | 7,000 | 37,310 | 7,000 | |
Jan 28 2021 | ONCT | Oncternal Therapeu ... | MAZANET ROSEMARY | Director | Option Exercise | A | 5.33 | 30,000 | 159,900 | 30,000 | |
Sep 02 2020 | ONCT | Oncternal Therapeu ... | CARTER MICHAEL G | Director | Buy | P | 2.10 | 71,429 | 150,001 | 71,947 | 518 to 71.9 K (+13,789.38 %) |
Sep 02 2020 | ONCT | Oncternal Therapeu ... | CARTER MICHAEL G | Director | Buy | P | 2.10 | 71,429 | 150,001 | 71,947 | 518 to 71.9 K (+13,789.38 %) |
Jul 23 2020 | ONCT | Oncternal Therapeu ... | KISNER DANIEL L | Director | Option Exercise | A | 2.32 | 5,000 | 11,600 | 5,000 | |
Jul 23 2020 | ONCT | Oncternal Therapeu ... | KISNER DANIEL L | Director | Buy | P | 2.38 | 10,000 | 23,825 | 10,000 | 0 to 10 K |
Jul 23 2020 | ONCT | Oncternal Therapeu ... | AKER HAZEL M | Legal Counsel | Option Exercise | A | 2.32 | 20,986 | 48,688 | 20,986 | |
Jul 23 2020 | ONCT | Oncternal Therapeu ... | AKER HAZEL M | Legal Counsel | Buy | P | 2.38 | 41,972 | 99,998 | 46,987 | 5 K to 47 K (+836.93 %) |
Jul 23 2020 | ONCT | Oncternal Therapeu ... | Shanghai Pharmaceutical (USA) ... | 10% Owner | Option Exercise | P | 2.32 | 524,658 | 1,217,207 | 524,658 | |
Jul 23 2020 | ONCT | Oncternal Therapeu ... | Shanghai Pharmaceutical (USA) ... | 10% Owner | Buy | P | 2.38 | 1,049,317 | 2,499,998 | 3,544,431 | 2.5 M to 3.5 M (+42.05 %) |
Jun 12 2020 | ONCT | Oncternal Therapeu ... | Wills Robert James | Director | Option Exercise | A | 2.94 | 15,000 | 44,100 | 15,000 |